Left Ventricular Mass of 97g: Clinical Significance and Management
A left ventricular mass of 97g falls within the normal range for both men and women, but the BSA-indexed value appears elevated, suggesting you need to verify the measurement method and patient sex to determine if true left ventricular hypertrophy (LVH) exists.
Understanding the Discrepancy
The confusion arises from comparing absolute LV mass (97g) against BSA-indexed reference ranges (39-73 g/m²). According to the 2015 ASE/EACVI guidelines 11, you must compare absolute mass to absolute reference ranges and indexed mass to indexed reference ranges:
Normal Absolute LV Mass Values:
- Women: 66-150g (2D method) or 67-162g (linear method)
- Men: 96-200g (2D method) or 88-224g (linear method)
Your patient's 97g absolute mass is normal for both sexes 1.
Normal BSA-Indexed LV Mass:
- Women: 44-88 g/m² (2D method) or 43-95 g/m² (linear method)
- Men: 50-102 g/m² (2D method) or 49-115 g/m² (linear method)
The upper limits of normal are 88 g/m² for women and 102 g/m² for men using 2D methods 1.
Critical Action Steps
1. Calculate the Actual BSA-Indexed Value
You need to divide the 97g by the patient's actual BSA. If the patient has a BSA of approximately 2.5 m², the indexed value would be 38.8 g/m² (well within normal). If BSA is 1.3 m², the indexed value would be 74.6 g/m² (borderline elevated for women).
2. Verify Measurement Method
Confirm whether the measurement used:
- Linear (M-mode) method: Upper limit 95 g/m² (women) or 115 g/m² (men)
- 2D method: Upper limit 88 g/m² (women) or 102 g/m² (men) 1
3. Assess for LVH Pattern if Truly Elevated
If the indexed value exceeds normal limits, calculate relative wall thickness (RWT) using: (2 × posterior wall thickness) / (LV internal diameter at end-diastole) 11
Categorize the pattern:
- RWT ≤ 0.42 with elevated LV mass = Eccentric hypertrophy
- RWT > 0.42 with elevated LV mass = Concentric hypertrophy (highest cardiovascular risk) 2
- RWT > 0.42 with normal LV mass = Concentric remodeling
Clinical Implications for Morbidity and Mortality
Concentric hypertrophy carries the highest risk for adverse cardiovascular events and mortality 2. The 2017 ACC/AHA hypertension guidelines note that LVH independently predicts future cardiovascular events, and BP lowering leads to LV mass reduction 3.
Management Algorithm:
If LV mass is truly elevated (indexed value above sex-specific cutoffs):
Screen for secondary causes of hypertension 3:
- Obtain fasting glucose, lipid profile, serum creatinine with eGFR, electrolytes, TSH, urinalysis, and ECG
- Consider urinary albumin-to-creatinine ratio
- Assess for symptoms suggesting secondary hypertension (weight changes, palpitations, muscle weakness suggesting hyperaldosteronism)
Initiate or optimize antihypertensive therapy:
Address cardiovascular risk factors:
Monitor for target organ damage:
- Assess left atrial size (predictor of atrial fibrillation)
- Evaluate diastolic function (precursor to heart failure with preserved ejection fraction)
- Serial echocardiography to track LV mass changes with treatment
Important Caveats
- Patients at extremes of height or BSA may be misclassified using standard reference ranges 11
- Lean body mass may be more appropriate than BSA for indexing in some populations 5, though this is not standard practice
- About 21% of patients with hypertrophic cardiomyopathy have normal LV mass index 6, so normal mass doesn't exclude all cardiac pathology
- The reference range you cited (39-73 g/m²) appears non-standard; use the validated ASE/EACVI cutoffs instead 11
Bottom line: Verify your calculation and measurement method before concluding LVH exists. An absolute mass of 97g is normal, but proper BSA indexing is essential for accurate diagnosis and risk stratification.